As of 4 Nov 2024, CytoDyn net assets is $-109.50M, an increase of 16.00% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the CytoDyn overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Year | Net assets | Change |
---|---|---|
2023 | $-109.50M | 16.00% |
2022 | $-94.40M | 349.13% |
2021 | $-21.02M | 747.16% |
2020 | $-2.48M | -98.92% |
2019 | $-229.03M | - |